查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867535

細胞庫外包：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Cell Banking Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球細胞庫外包市場規模估計為 93.72 億美元，預計到 2031 年將達到 264.85 億美元，在預測期（2025-2031 年）內複合年成長率為 16.1%。

細胞庫外包是指將細胞樣本（例如幹細胞、免疫細胞和基因工程細胞）的採集、處理、擴增和儲存等關鍵流程外包給專業的第三方服務供應商。這些服務包括符合GMP標準的標準化生物銀行流程、嚴格的品管以及貫穿整個生命週期的資料可追溯性。隨著精準醫療、細胞療法和生物製藥研發的快速發展，細胞庫外包正成為全球醫療保健和生命科學產業的重要基礎設施，彌合了臨床研究與商業應用之間的鴻溝。

全球生物製藥產業正經歷結構性轉型，細胞和基因療法等新興治療方法推動了對大規模、高品質細胞樣本庫需求的激增。為了提高效率並減輕營運負擔，生技公司擴大採用輕資產研發模式，將細胞庫建置、品管(QC) 和儲存作業外包給擁有 GMP 或 ISO 認證的專業供應商。同時，中國、美國、韓國和新加坡等國的國家政策繼續將細胞庫建設作為戰略基礎設施發展的重點。這些因素共同推動了細胞庫外包市場的快速成長，並作為關鍵基礎設施服務吸引了資本和產業的注意。然而，儘管需求強勁，該產業仍面臨許多挑戰。全球監管差異，尤其是在跨境檢體轉移、倫理審查和資料主權等領域，造成了合規的複雜性。該行業的准入門檻很高，需要對基礎設施、合格人員和品質系統進行大量投資。客戶對資料完整性、生物安全性和長期儲存可靠性的期望不斷提高，也推動了市場整合。因此，大型供應商正在鞏固其市場地位，而小型企業則面臨日益成長的營運和競爭壓力。市場需求正從早期學術和研究應用轉向後期和商業性臨床項目，尤其是CAR-T療法、基於iPS細胞的再生醫學和個人化免疫療法。 III期及以上階段的試驗需要更嚴格的樣本處理和儲存通訊協定。此外，全球製藥公司和CRO/CMO正在重組其供應鏈，推動採用多點採集、區域生物銀行和即時數位追溯系統。在這個快速成熟的市場環境中，提供整合化、自動化且完全合規服務的供應商將獲得優勢，並成為以平台為中心、主要企業。

本報告旨在按地區/國家、類型和應用對全球細胞庫外包市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以收益為準，以2024年為基準年，對細胞庫外包市場規模、估算和預測進行了分析，並包含了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就細胞庫外包業務做出明智的決策。

市場區隔

公司

  • SGS Life Sciences
  • Lonza
  • CCBC
  • Vcanbio
  • AMAG Pharmaceuticals
  • ViaCord
  • Thermo Fisher
  • Wuxi Apptec
  • CordLife
  • Esperite
  • Reliance Life Sciences
  • Lifecell
  • Cryo-Cell
  • Toxikon
  • Goodwin Biotechnology
  • Texcell
  • Cryo Stemcell

按類型分類的細分市場

  • 幹細胞庫
  • 非幹細胞庫

應用領域

  • 細胞庫儲存
  • 銀行特徵分析與測試
  • 細胞庫製備

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Cell Banking Outsourcing was estimated to be worth US$ 9372 million in 2024 and is forecast to a readjusted size of US$ 26485 million by 2031 with a CAGR of 16.1% during the forecast period 2025-2031.

Cell Banking Outsourcing refers to the practice of delegating the critical processes of collecting, processing, expanding, and storing cell samples-such as stem cells, immune cells, or genetically engineered cells-to specialized third-party service providers. This service involves standardized GMP-compliant biobanking procedures, stringent quality control, and full lifecycle data traceability. With the rapid expansion of precision medicine, cell therapies, and biopharmaceutical R&D, outsourced cell banking is becoming a vital infrastructure across the global healthcare and life sciences industries, bridging the gap from clinical research to commercial application.

The global biopharmaceutical sector is undergoing structural transformation, with emerging therapies such as cell and gene therapy driving a surge in demand for large-scale, high-quality cell sample banking. Biotech companies are increasingly favoring asset-light R&D models, outsourcing cell banking, QC, and storage to specialized providers with GMP or ISO certifications to enhance efficiency and reduce operational burden. Meanwhile, national policies in countries like China, the U.S., South Korea, and Singapore continue to prioritize cell banking as a strategic infrastructure initiative. These factors jointly propel the Cell Banking Outsourcing market into a high-growth trajectory, attracting both capital and industry attention as a critical enabling service. Despite strong demand, the sector faces considerable hurdles. Global disparities in regulation-especially in areas such as sample cross-border transfer, ethical approvals, and data sovereignty-present compliance complexities. The industry has high entry barriers, requiring significant investment in infrastructure, certified personnel, and quality systems. Client expectations around data integrity, biosafety, and long-term storage reliability are also rising, leading to market consolidation. As a result, while leading providers strengthen their positions, smaller players face increasing operational and competitive pressures.Demand is shifting from early-stage academic and research applications to late-phase and commercial clinical programs, especially in CAR-T, iPSC-based regenerative therapies, and personalized immunotherapies. Phase III+ trials require stricter sample handling and storage protocols. Additionally, global pharma and CRO/CMO players are reshaping their supply chains, driving the adoption of multi-site collection, regionalized biobanking, and real-time digital traceability systems. The future will favor providers offering integrated, automated, and fully compliant services-emerging as platform-centric and ecosystem-leading companies in a rapidly maturing landscape.

This report aims to provide a comprehensive presentation of the global market for Cell Banking Outsourcing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell Banking Outsourcing by region & country, by Type, and by Application.

The Cell Banking Outsourcing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Banking Outsourcing.

Market Segmentation

By Company

  • SGS Life Sciences
  • Lonza
  • CCBC
  • Vcanbio
  • AMAG Pharmaceuticals
  • ViaCord
  • Thermo Fisher
  • Wuxi Apptec
  • CordLife
  • Esperite
  • Reliance Life Sciences
  • Lifecell
  • Cryo-Cell
  • Toxikon
  • Goodwin Biotechnology
  • Texcell
  • Cryo Stemcell

Segment by Type

  • Stem Cell Banking
  • Non-stem Cell Banking

Segment by Application

  • Cell Bank Storage
  • Bank Characterization and Testing
  • Cell Bank Preparation

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cell Banking Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Cell Banking Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Cell Banking Outsourcing in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cell Banking Outsourcing Product Introduction
  • 1.2 Global Cell Banking Outsourcing Market Size Forecast (2020-2031)
  • 1.3 Cell Banking Outsourcing Market Trends & Drivers
    • 1.3.1 Cell Banking Outsourcing Industry Trends
    • 1.3.2 Cell Banking Outsourcing Market Drivers & Opportunity
    • 1.3.3 Cell Banking Outsourcing Market Challenges
    • 1.3.4 Cell Banking Outsourcing Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cell Banking Outsourcing Players Revenue Ranking (2024)
  • 2.2 Global Cell Banking Outsourcing Revenue by Company (2020-2025)
  • 2.3 Key Companies Cell Banking Outsourcing Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Cell Banking Outsourcing Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Cell Banking Outsourcing
  • 2.6 Cell Banking Outsourcing Market Competitive Analysis
    • 2.6.1 Cell Banking Outsourcing Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Cell Banking Outsourcing Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Banking Outsourcing as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Stem Cell Banking
    • 3.1.2 Non-stem Cell Banking
  • 3.2 Global Cell Banking Outsourcing Sales Value by Type
    • 3.2.1 Global Cell Banking Outsourcing Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cell Banking Outsourcing Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cell Banking Outsourcing Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Cell Bank Storage
    • 4.1.2 Bank Characterization and Testing
    • 4.1.3 Cell Bank Preparation
  • 4.2 Global Cell Banking Outsourcing Sales Value by Application
    • 4.2.1 Global Cell Banking Outsourcing Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cell Banking Outsourcing Sales Value, by Application (2020-2031)
    • 4.2.3 Global Cell Banking Outsourcing Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cell Banking Outsourcing Sales Value by Region
    • 5.1.1 Global Cell Banking Outsourcing Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cell Banking Outsourcing Sales Value by Region (2020-2025)
    • 5.1.3 Global Cell Banking Outsourcing Sales Value by Region (2026-2031)
    • 5.1.4 Global Cell Banking Outsourcing Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.2.2 North America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.3.2 Europe Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Cell Banking Outsourcing Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.5.2 South America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Cell Banking Outsourcing Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cell Banking Outsourcing Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cell Banking Outsourcing Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.3.2 United States Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.4.2 Europe Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.5.2 China Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.6.2 Japan Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.7.2 South Korea Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cell Banking Outsourcing Sales Value, 2020-2031
    • 6.9.2 India Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cell Banking Outsourcing Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 SGS Life Sciences
    • 7.1.1 SGS Life Sciences Profile
    • 7.1.2 SGS Life Sciences Main Business
    • 7.1.3 SGS Life Sciences Cell Banking Outsourcing Products, Services and Solutions
    • 7.1.4 SGS Life Sciences Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.1.5 SGS Life Sciences Recent Developments
  • 7.2 Lonza
    • 7.2.1 Lonza Profile
    • 7.2.2 Lonza Main Business
    • 7.2.3 Lonza Cell Banking Outsourcing Products, Services and Solutions
    • 7.2.4 Lonza Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Lonza Recent Developments
  • 7.3 CCBC
    • 7.3.1 CCBC Profile
    • 7.3.2 CCBC Main Business
    • 7.3.3 CCBC Cell Banking Outsourcing Products, Services and Solutions
    • 7.3.4 CCBC Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.3.5 CCBC Recent Developments
  • 7.4 Vcanbio
    • 7.4.1 Vcanbio Profile
    • 7.4.2 Vcanbio Main Business
    • 7.4.3 Vcanbio Cell Banking Outsourcing Products, Services and Solutions
    • 7.4.4 Vcanbio Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Vcanbio Recent Developments
  • 7.5 AMAG Pharmaceuticals
    • 7.5.1 AMAG Pharmaceuticals Profile
    • 7.5.2 AMAG Pharmaceuticals Main Business
    • 7.5.3 AMAG Pharmaceuticals Cell Banking Outsourcing Products, Services and Solutions
    • 7.5.4 AMAG Pharmaceuticals Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.5.5 AMAG Pharmaceuticals Recent Developments
  • 7.6 ViaCord
    • 7.6.1 ViaCord Profile
    • 7.6.2 ViaCord Main Business
    • 7.6.3 ViaCord Cell Banking Outsourcing Products, Services and Solutions
    • 7.6.4 ViaCord Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.6.5 ViaCord Recent Developments
  • 7.7 Thermo Fisher
    • 7.7.1 Thermo Fisher Profile
    • 7.7.2 Thermo Fisher Main Business
    • 7.7.3 Thermo Fisher Cell Banking Outsourcing Products, Services and Solutions
    • 7.7.4 Thermo Fisher Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Thermo Fisher Recent Developments
  • 7.8 Wuxi Apptec
    • 7.8.1 Wuxi Apptec Profile
    • 7.8.2 Wuxi Apptec Main Business
    • 7.8.3 Wuxi Apptec Cell Banking Outsourcing Products, Services and Solutions
    • 7.8.4 Wuxi Apptec Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Wuxi Apptec Recent Developments
  • 7.9 CordLife
    • 7.9.1 CordLife Profile
    • 7.9.2 CordLife Main Business
    • 7.9.3 CordLife Cell Banking Outsourcing Products, Services and Solutions
    • 7.9.4 CordLife Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.9.5 CordLife Recent Developments
  • 7.10 Esperite
    • 7.10.1 Esperite Profile
    • 7.10.2 Esperite Main Business
    • 7.10.3 Esperite Cell Banking Outsourcing Products, Services and Solutions
    • 7.10.4 Esperite Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Esperite Recent Developments
  • 7.11 Reliance Life Sciences
    • 7.11.1 Reliance Life Sciences Profile
    • 7.11.2 Reliance Life Sciences Main Business
    • 7.11.3 Reliance Life Sciences Cell Banking Outsourcing Products, Services and Solutions
    • 7.11.4 Reliance Life Sciences Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Reliance Life Sciences Recent Developments
  • 7.12 Lifecell
    • 7.12.1 Lifecell Profile
    • 7.12.2 Lifecell Main Business
    • 7.12.3 Lifecell Cell Banking Outsourcing Products, Services and Solutions
    • 7.12.4 Lifecell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Lifecell Recent Developments
  • 7.13 Cryo-Cell
    • 7.13.1 Cryo-Cell Profile
    • 7.13.2 Cryo-Cell Main Business
    • 7.13.3 Cryo-Cell Cell Banking Outsourcing Products, Services and Solutions
    • 7.13.4 Cryo-Cell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Cryo-Cell Recent Developments
  • 7.14 Toxikon
    • 7.14.1 Toxikon Profile
    • 7.14.2 Toxikon Main Business
    • 7.14.3 Toxikon Cell Banking Outsourcing Products, Services and Solutions
    • 7.14.4 Toxikon Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Toxikon Recent Developments
  • 7.15 Goodwin Biotechnology
    • 7.15.1 Goodwin Biotechnology Profile
    • 7.15.2 Goodwin Biotechnology Main Business
    • 7.15.3 Goodwin Biotechnology Cell Banking Outsourcing Products, Services and Solutions
    • 7.15.4 Goodwin Biotechnology Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Goodwin Biotechnology Recent Developments
  • 7.16 Texcell
    • 7.16.1 Texcell Profile
    • 7.16.2 Texcell Main Business
    • 7.16.3 Texcell Cell Banking Outsourcing Products, Services and Solutions
    • 7.16.4 Texcell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Texcell Recent Developments
  • 7.17 Cryo Stemcell
    • 7.17.1 Cryo Stemcell Profile
    • 7.17.2 Cryo Stemcell Main Business
    • 7.17.3 Cryo Stemcell Cell Banking Outsourcing Products, Services and Solutions
    • 7.17.4 Cryo Stemcell Cell Banking Outsourcing Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Cryo Stemcell Recent Developments

8 Industry Chain Analysis

  • 8.1 Cell Banking Outsourcing Industrial Chain
  • 8.2 Cell Banking Outsourcing Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cell Banking Outsourcing Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cell Banking Outsourcing Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Cell Banking Outsourcing Market Trends
  • Table 2. Cell Banking Outsourcing Market Drivers & Opportunity
  • Table 3. Cell Banking Outsourcing Market Challenges
  • Table 4. Cell Banking Outsourcing Market Restraints
  • Table 5. Global Cell Banking Outsourcing Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Cell Banking Outsourcing Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Cell Banking Outsourcing Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Cell Banking Outsourcing Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Cell Banking Outsourcing
  • Table 10. Global Cell Banking Outsourcing Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Banking Outsourcing as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Cell Banking Outsourcing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Cell Banking Outsourcing Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Cell Banking Outsourcing Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Cell Banking Outsourcing Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Cell Banking Outsourcing Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Cell Banking Outsourcing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Cell Banking Outsourcing Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Cell Banking Outsourcing Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Cell Banking Outsourcing Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Cell Banking Outsourcing Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Cell Banking Outsourcing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Cell Banking Outsourcing Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Cell Banking Outsourcing Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Cell Banking Outsourcing Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Cell Banking Outsourcing Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Cell Banking Outsourcing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Cell Banking Outsourcing Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Cell Banking Outsourcing Sales Value, (2026-2031) & (US$ Million)
  • Table 31. SGS Life Sciences Basic Information List
  • Table 32. SGS Life Sciences Description and Business Overview
  • Table 33. SGS Life Sciences Cell Banking Outsourcing Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Cell Banking Outsourcing Business of SGS Life Sciences (2020-2025)
  • Table 35. SGS Life Sciences Recent Developments
  • Table 36. Lonza Basic Information List
  • Table 37. Lonza Description and Business Overview
  • Table 38. Lonza Cell Banking Outsourcing Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Cell Banking Outsourcing Business of Lonza (2020-2025)
  • Table 40. Lonza Recent Developments
  • Table 41. CCBC Basic Information List
  • Table 42. CCBC Description and Business Overview
  • Table 43. CCBC Cell Banking Outsourcing Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Cell Banking Outsourcing Business of CCBC (2020-2025)
  • Table 45. CCBC Recent Developments
  • Table 46. Vcanbio Basic Information List
  • Table 47. Vcanbio Description and Business Overview
  • Table 48. Vcanbio Cell Banking Outsourcing Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Cell Banking Outsourcing Business of Vcanbio (2020-2025)
  • Table 50. Vcanbio Recent Developments
  • Table 51. AMAG Pharmaceuticals Basic Information List
  • Table 52. AMAG Pharmaceuticals Description and Business Overview
  • Table 53. AMAG Pharmaceuticals Cell Banking Outsourcing Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Cell Banking Outsourcing Business of AMAG Pharmaceuticals (2020-2025)
  • Table 55. AMAG Pharmaceuticals Recent Developments
  • Table 56. ViaCord Basic Information List
  • Table 57. ViaCord Description and Business Overview
  • Table 58. ViaCord Cell Banking Outsourcing Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Cell Banking Outsourcing Business of ViaCord (2020-2025)
  • Table 60. ViaCord Recent Developments
  • Table 61. Thermo Fisher Basic Information List
  • Table 62. Thermo Fisher Description and Business Overview
  • Table 63. Thermo Fisher Cell Banking Outsourcing Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Cell Banking Outsourcing Business of Thermo Fisher (2020-2025)
  • Table 65. Thermo Fisher Recent Developments
  • Table 66. Wuxi Apptec Basic Information List
  • Table 67. Wuxi Apptec Description and Business Overview
  • Table 68. Wuxi Apptec Cell Banking Outsourcing Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Cell Banking Outsourcing Business of Wuxi Apptec (2020-2025)
  • Table 70. Wuxi Apptec Recent Developments
  • Table 71. CordLife Basic Information List
  • Table 72. CordLife Description and Business Overview
  • Table 73. CordLife Cell Banking Outsourcing Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Cell Banking Outsourcing Business of CordLife (2020-2025)
  • Table 75. CordLife Recent Developments
  • Table 76. Esperite Basic Information List
  • Table 77. Esperite Description and Business Overview
  • Table 78. Esperite Cell Banking Outsourcing Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Cell Banking Outsourcing Business of Esperite (2020-2025)
  • Table 80. Esperite Recent Developments
  • Table 81. Reliance Life Sciences Basic Information List
  • Table 82. Reliance Life Sciences Description and Business Overview
  • Table 83. Reliance Life Sciences Cell Banking Outsourcing Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Cell Banking Outsourcing Business of Reliance Life Sciences (2020-2025)
  • Table 85. Reliance Life Sciences Recent Developments
  • Table 86. Lifecell Basic Information List
  • Table 87. Lifecell Description and Business Overview
  • Table 88. Lifecell Cell Banking Outsourcing Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Cell Banking Outsourcing Business of Lifecell (2020-2025)
  • Table 90. Lifecell Recent Developments
  • Table 91. Cryo-Cell Basic Information List
  • Table 92. Cryo-Cell Description and Business Overview
  • Table 93. Cryo-Cell Cell Banking Outsourcing Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Cell Banking Outsourcing Business of Cryo-Cell (2020-2025)
  • Table 95. Cryo-Cell Recent Developments
  • Table 96. Toxikon Basic Information List
  • Table 97. Toxikon Description and Business Overview
  • Table 98. Toxikon Cell Banking Outsourcing Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Cell Banking Outsourcing Business of Toxikon (2020-2025)
  • Table 100. Toxikon Recent Developments
  • Table 101. Goodwin Biotechnology Basic Information List
  • Table 102. Goodwin Biotechnology Description and Business Overview
  • Table 103. Goodwin Biotechnology Cell Banking Outsourcing Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Cell Banking Outsourcing Business of Goodwin Biotechnology (2020-2025)
  • Table 105. Goodwin Biotechnology Recent Developments
  • Table 106. Texcell Basic Information List
  • Table 107. Texcell Description and Business Overview
  • Table 108. Texcell Cell Banking Outsourcing Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Cell Banking Outsourcing Business of Texcell (2020-2025)
  • Table 110. Texcell Recent Developments
  • Table 111. Cryo Stemcell Basic Information List
  • Table 112. Cryo Stemcell Description and Business Overview
  • Table 113. Cryo Stemcell Cell Banking Outsourcing Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Cell Banking Outsourcing Business of Cryo Stemcell (2020-2025)
  • Table 115. Cryo Stemcell Recent Developments
  • Table 116. Key Raw Materials Lists
  • Table 117. Raw Materials Key Suppliers Lists
  • Table 118. Cell Banking Outsourcing Downstream Customers
  • Table 119. Cell Banking Outsourcing Distributors List
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Cell Banking Outsourcing Product Picture
  • Figure 2. Global Cell Banking Outsourcing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Cell Banking Outsourcing Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Cell Banking Outsourcing Report Years Considered
  • Figure 5. Global Cell Banking Outsourcing Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell Banking Outsourcing Revenue in 2024
  • Figure 7. Cell Banking Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Stem Cell Banking Picture
  • Figure 9. Non-stem Cell Banking Picture
  • Figure 10. Global Cell Banking Outsourcing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Cell Banking Outsourcing Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Cell Bank Storage
  • Figure 13. Product Picture of Bank Characterization and Testing
  • Figure 14. Product Picture of Cell Bank Preparation
  • Figure 15. Global Cell Banking Outsourcing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Cell Banking Outsourcing Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Cell Banking Outsourcing Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Cell Banking Outsourcing Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Cell Banking Outsourcing Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Cell Banking Outsourcing Sales Value (%), (2020-2031)
  • Figure 28. United States Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Cell Banking Outsourcing Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Cell Banking Outsourcing Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Cell Banking Outsourcing Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Cell Banking Outsourcing Industrial Chain
  • Figure 50. Cell Banking Outsourcing Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed